Based: Redwood City, CA
Amount: $65 million
Investors: Capricorn Management and U.S. Venture Partners
Scoop: HeartFlow had raised $65 million of a hoped for $75 million as 2011 came to a close. And as of mid-February, the company had raised almost all of the $75 million. The Redwood City, CA-based company is evaluating noninvasive technology to cut down on unnecessary heart procedures. With its technology, the company hopes to identify those patients who need invasive procedures, as well as those who don't. HeartFlow's web-based technology calculates fractional flow reserve from 3-D computational models of the aorta and heart gathered from CT scan data. Cardiovascular imaging and diagnostics represents a big opportunity, and a number of big companies are trying to make inroads, as MedCity News notes. For example, Boston Scientific ($BSX) has an FFR/optical coherence tomography diagnostic tool that was cleared in Europe last summer. But HeartFlow is looking to attract big talent to make sure it remains on top. In February, Cordis CSO Campbell Rogers left his post to become CMO of HeartFlow, as MassDevice reports.